Eradicating the Enemy Within: A Narrative Review of Malaria Elimination Strategies and Future Pathways in Nigeria
Keywords:
Long-lasting insecticide treated nets, Malaria elimination, Plasmodium falciparum, R21/Matrix-M, RTS, S/AS01, Vaccine implementationAbstract
Despite decades of coordinated national and international effort, the elimination targets embedded in the National Malaria Strategic Plan 2021 to 2025 remain substantially unmet, exposing a persistent and deeply rooted gap between the demonstrated efficacy of available tools and their real-world programmatic impact. This narrative review critically synthesises current evidence on both established and emerging malaria elimination strategies in Nigeria, examining the implementation landscape across six interrelated domains: vector control, case management and chemoprevention, diagnostic accuracy, malaria vaccination, mobile health surveillance, and genetic vector control. A comprehensive literature search was conducted across PubMed, Google Scholar, Web of Science, and EMBASE, supplemented by grey literature from the World Health Organization, the National Malaria Elimination Programme, and Gavi, with priority given to publications from 2015 to 2025. The review finds that existing tools, including long-lasting insecticide treated nets, artemisinin-based combination therapies, seasonal malaria chemoprevention, and indoor residual spraying, have produced measurable but insufficient reductions in burden, constrained by insecticide resistance, low utilisation rates, supply chain fragility, and weak diagnostic infrastructure. Inaccuracies in rapid diagnostic test performance substantially drive misdiagnosis and fuel antimalarial resistance in Nigeria, with deletions in the hrp2 and hrp3 genes of Plasmodium falciparum emerging as a particularly consequential threat to the reliability of frontline testing. The December 2024 rollout of the R21/Matrix-M vaccine in Bayelsa and Kebbi States represents a historic national milestone, though implementation barriers encompassing vaccine hesitancy, cold chain limitations, health workforce gaps, and the complexity of the four-dose schedule demand systematic and urgent responses. The overarching finding of this review is that no single intervention, however efficacious in trial settings, is sufficient to achieve malaria elimination in Nigeria, and that what is required is a systems-level, integrated strategy aligning biological innovation with health system strengthening, equitable financing, digital infrastructure, and genuine community partnership.
References
Duodu, P. A., Dzomeku, V. M., Emerole, C. O., Agbadi, P., Arthur-Holmes, F., & Nutor, J. J. (2022). Rural–urban dimensions of the perception of malaria severity and practice of malaria preventive measures: insight from the 2018 Nigeria Demographic and Health Survey. Journal of Biosocial Science, 54(5), 858-875.
Aderinto, N., Olatunji, G., Kokori, E., Sikirullahi, S., Aboje, J. E., & Ojabo, R. E. (2024). A perspective on Oxford’s R21/Matrix-M™ malaria vaccine and the future of global eradication efforts. Malaria journal, 23(1), 16.
Akinwale, O. D., Okereke, P. U., Akinbowale, B. T., Awosanya, F. O., Abdulsalam, B. O., Akintola, A. B., ... & Okeke, A. C. (2026). Assessing the effectiveness of current malaria control strategies in Nigeria: a systematic review and meta-analysis. International Journal of Medicine and Health Development, 31(1), 28-38.
Osuntoye, S. D., Umar, A. B., Solotan, A. R. T., & Sokunbi, T. O. (2025). Rollout of malaria vaccine in Nigeria: lessons from other African countries. Discover Public Health, 22(1), 159.
Benedict, M. Q., Burt, A., Capurro, M. L., De Barro, P., Handler, A. M., Hayes, K. R., ... & Adelman, Z. N. (2018). Recommendations for laboratory containment and management of gene drive systems in arthropods. Vector-Borne and Zoonotic Diseases, 18(1), 2-13.
Datoo, M. S., Dicko, A., Tinto, H., Ouédraogo, J. B., Hamaluba, M., Olotu, A., ... & Valea, I. (2024). Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. The Lancet, 403(10426), 533-544.
Duffy, P. E., & Patrick Gorres, J. (2020). Malaria vaccines since 2000: progress, priorities, products. npj Vaccines, 5(1), 48.
Economic Impact of Malaria in Nigeria. (2019). Nigerian Health Journal, 17(4), 350–365.
Chibueze, O. V., Moses, D. T., Buba, B., Chinasa, N. P., Gabriel, O. C., Ezeunala, M. N., & Ezaka, E. I. (2021). Knowledge, Attitude and Practices towards Malaria and the Use of Insecticide-Treated Net among Rural Dwellers in Mubi North Local Government Area, Adamawa State, Nigeria. International Journal of TROPICAL DISEASE & Health, 42(2), 19-29.
Federal Ministry of Health (FMOH). (2019). National malaria strategic plan. FMOH Publications, Abuja.
Ferrari, R. (2015). Writing narrative style literature reviews. Medical writing, 24(4), 230-235.
Hassan, I. A., Araoye, J. B., Olawuyi, D. A., & Effiong, F. B. (2025). Malaria vaccine implementation in Nigeria: Addressing the coverage challenges within the national immunization program for high impact. Vaccine, 61, 127376.
Leftwich PT, Spurgin LG, Harvey-Samuel T, Thomas CJ, Paladino LC, Edgington MP, Alphey L. Genetic pest management and the background genetics of release strains. Philosophical Transactions of the Royal Society B: Biological Sciences. 2021 Feb 15;376(1818).
Maduka, O. (2018). End malaria for good: A review of current strategies and future novelties for malaria elimination in Nigeria. Malaria World Journal, 9, 1.
Nadeem, A. Y., Shehzad, A., Islam, S. U., Al-Suhaimi, E. A., & Lee, Y. S. (2022). Mosquirix™ RTS, S/AS01 vaccine development, immunogenicity, and efficacy. Vaccines, 10(5), 713.
National Malaria Elimination Programme (NMEP). (2021). National malaria strategic plan 2021–2025. Federal Ministry of Health, Abuja.
Oboh, M. A., Oyebola, K. M., Ajibola, O., & Thomas, B. N. (2022). Nigeria at 62: Quagmire of malaria and the urgent need for deliberate and concerted control strategy. Frontiers in Tropical Diseases, 3, 1074751.
Ogbonna E. K. (2024). Malaria Prevention and Control in Nigeria: Evaluating the Effectiveness of Current Strategies. Newport International Journal of Research in Medical Sciences, 5(3): 76 -79.
Okereke, P. U., Ayodeji, B. M., Bolarinwa, R. T., Ayodeji, O. D., Popoola, I. O., Okereke, W. O., ... & Tola, O. S. (2025). Assessing the influence of rapid diagnostic test (RDT) accuracy on malaria misdiagnosis and antimalarial resistance in Nigeria. Annals of Medicine and Surgery, 87(2), 658-662.
Okereke, P. U., Kemuel, K., Abdullahi, M., Ede, W. O., Okereke, W. O., Nzubechukwu, O., ... & Okeke, A. C. (2025). Implementation of malaria vaccine in Nigeria: challenges and recommendations. IJS Global Health, 8(4), e00577.
Okereke PU, Okereke OW, Ogunyinka BO, Aluele SI, Tiamiyu RA, Afolabi MA, Umeh CV, Nwibo EU, Ibekwe SN, Ogbu AC, Okwor EO. Mobile app-based malaria surveillance and vector control integration: a scoping review of evidence from endemic settings. Malaria Journal. 2025 Dec;24(1):412.
Okwelogu, I. S., Amakiri, P. C., Ahanonu, G. E., Dimgba, O. O., Ezeigwe, J. O., Obi, C. G., & Nwabueze, C. (2021). A Review of the Effectiveness of Adopted, Applied, and Recommended Malaria Control Techniques within the Southeast Region of Nigeria. American Journal of Public Health, 9(6), 244-247.
Powell, J.R. (2022). Modifying mosquitoes to suppress disease transmission: Is the long wait over? Genetics, 221(3), iyac072. https://doi.org/10.1093/genetics/iyac072
World Health Organization (WHO). (2019). World malaria report 2019. WHO Regional Office for Africa, Brazzaville.
World Health Organization (WHO). (2023). WHO recommends R21/Matrix-M vaccine for malaria prevention in updated advice on immunization. https://www.who.int/news/item/02-10-2023
World Health Organization (WHO). (2024). World malaria report 2024. https://www.who.int/publications/i/item/9789240101395
World Health Organization Regional Office for Africa (WHO/AFRO). (2024). Nigeria introduces the R21 vaccine in a pivotal move for malaria control. https://www.afro.who.int/countries/nigeria
Zapletal, J., Najmitabrizi, N., Erraguntla, M., Lawley, M. A., Myles, K. M., & Adelman, Z. N. (2021). Making gene drive biodegradable. Philosophical Transactions of the Royal Society B: Biological Sciences, 376(1818).
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Promise U. OKEREKE, Dorcas A. ADENIYI, Mulikat T. ADEDEJI, Sheriff O. AKINOLA, Wisdom O. OKEREKE, Chukwuma F. OZIOMA, Ogechi G. OKOLI, Chikamso O. Chibueze, Nzubechukwu OGAMBA, Collins U. UCHE
This work is licensed under a Creative Commons Attribution 4.0 International License.
